The supply of Handok’s ‘Sabril Tab’ that was recalled by the company is expected to smoothen up soon. Its recall was issued by the health authorities due to the discovery of a small amount of an active pharmaceutical ingredient for a different drug, ‘tiapride,’ in its main active pharmaceutical ingredient, ‘vigabatrin.’

The Ministry of Food and Drug Safety (Minister Yu-Kyung Oh) said on the 18th, “We are aware of the concerns over the lack of epilepsy and infantile spasm treatment Sabril being raised by the industry. We have been discussing measures with Korea’s Children's Hospital Association, seeking expert advice, and meeting with the industry to closely understand the need and supply stat